Dr. Wang has extensive experience in laser treatments for the entire range of vision disorders: nearsightedness, farsightedness, astigmatism, and presbyopia . His area of expertise includes scientific research and clinical care. In addition to editing textbooks on corneal imaging technology as well as irregular astigmatism, he has published scientific papers in prestigious journals such as Nature (360:606;1992), contributed to several books on refractive surgery and corneal disease, and lectures at major international conferences annually.

He is the chief scientific officer of EyeVU , a joint venture biotech company co-owned by Vanderbilt University and Dr. Wang. He developed the world's first amniotic contact lens for which he received a US patent. As the principle investigator of an NIH grant, Dr. Wang demonstrated success of this technology in reducing corneal scar formation following trauma. It may reduce the incidence of corneal related blindness worldwide. In addition to the amniotic contact lens, he has developed another novel corneal wound healing technology, PEMF treatment, for non-healing corneal ulcers (EyeMag).

In addition to graduating magna cum laude from Harvard Medical School in 1991, Dr. Wang has received numerous awards including the "Lamport Prize for the Best Original Paper in Biomedical Research" from Harvard in 1991, the Lawrence Research Award from the Association of Research for Vision and Ophthalmology in 1995, the Heed Fellowship in 1996, the outstanding young faculty award from Vanderbilt University in 1998, and Fight for Sight Research Foundation grant award in 1998.

Dr. Wang is an internationally recognized teacher in LASIK vision correction. Since 1997, he has taught several major international courses in LASIK and has personally certified LASIK surgeons worldwide. He remains the doctor's choice when physicians choose LASIK for vision correction. He has successfully performed thousands of LASIK procedures and was a "VISX Star Surgeon". He served as a panel consultant on the US FDA Ophthalmic Device Panel which oversees the evaluation and approval for refractive technologies for US, and was a primary reviewer for LASIK at the historical FDA hearing for LASIK in July of 1999.

As the Director of the renowned Wang Vision Institute, Dr. Wang has built a state-of-the-art laser facility for refractive surgery. With the latest technology, Dr. Wang and his team provide a wide range of laser treatments for myopia, astigmatism and hyperopia including photo refractive keratectomy (PRK), laser in-situ keratomileusis (LASIK) and conductive keratoplasty (CK).

As a fellowship-trained corneal specialist, Dr. Wang is frequently consulted for the management of anterior segment complications by doctors from around the world, and patients who have had complications from eye surgery often visit for help.

Inspirational, Musician, Entertainers, MIT, Teacher, Music Producer, Scientists, Business Founders, Medicine, Ophthalmologist, Ballroom Dancer, Chinese American Culture, Chinese Speaking, Celebrity Harvard, Music,